You have 9 free searches left this month | for more free features.

Tolterodine

Showing 1 - 25 of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)

Not yet recruiting
  • Female Patients With Overactive Bladder Syndrome
  • tolterodine
  • +2 more
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023

Overactive Bladder, Obstructive Sleep Apnea, Overactive Bladder Syndrome Trial in Van (Tolterodine Tartrate 4 MG, Continuous

Completed
  • Overactive Bladder
  • +2 more
  • Tolterodine Tartrate 4 MG
  • Continuous positive airway pressure therapy (CPAP)
  • Van, Turkey
    Yuzuncu Yıl University
Feb 10, 2022

Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)

Completed
  • Urinary Incontinence
  • Urgency Urinary
  • Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
  • Boston, Massachusetts
    Brigham & Women's Hospital
Oct 21, 2022

Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,

Recruiting
  • Urinary Incontinence, Urge
  • +5 more
  • Tolterodine Tartrate ER
  • +2 more
  • Palo Alto, California
  • +1 more
Dec 7, 2022

Urinary Bladder, Overactive Trial in Singapore (tolterodine tartrate)

Completed
  • Urinary Bladder, Overactive
  • tolterodine tartrate
  • Singapore, Singapore
    Pfizer Investigational Site
Jan 26, 2021

.(Post Marketing Commitment Plan)

Completed
  • Overactive Bladder
  • Tolterodine tartrate
  • (no location specified)
Jan 26, 2021

Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence Trial in Cairo

Completed
  • Female Patients With Overactive Bladder Syndrome or Female Patients With Urgency or Urgency Urinary Incontinence
  • Low dose tadalafil 5 mg
  • +2 more
  • Cairo, Egypt
    Samer Morsy
Aug 11, 2022

Urinary Incontinence Trial in China (tolterodine extended release capsule)

Completed
  • Urinary Incontinence
  • tolterodine extended release capsule
  • Beijing, Beijing, China
  • +6 more
Jan 26, 2021

Overactive Bladder Trial in San Francisco (Tolterodine ER, Placebo)

Terminated
  • Overactive Bladder
  • Tolterodine ER
  • Placebo
  • San Francisco, California
  • +1 more
Jan 26, 2021

Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

Recruiting
  • Sjogren's Syndrome
  • Overactive Bladder Syndrome
  • Taichung, Taiwan
    China Medical University Hospital
Aug 8, 2021

Urinary Incontinence Trial in United Kingdom (Tolterodine ER, Placebo)

Completed
  • Urinary Incontinence
  • Tolterodine ER
  • Placebo
  • Blackburn, Lancashire, United Kingdom
  • +10 more
Jan 26, 2021

Memory, Cognition Trial in United States (Tolterodine ER, Oxybutynin ER)

Completed
  • Memory
  • Cognition
  • Tolterodine ER
  • Oxybutynin ER
  • Tucson, Arizona
  • +8 more
Jan 26, 2021

Overactive Bladder Trial in Zurich (Tolterodine, Filling cystometry, Intravesical neurostimulation)

Completed
  • Overactive Bladder
  • Tolterodine
  • +2 more
  • Zurich, Switzerland
    Pfizer Investigational Site
Jan 26, 2021

Urinary Incontinence Trial (tolterodine SR, overactive bladder)

Completed
  • Urinary Incontinence
  • tolterodine SR, overactive bladder
  • (no location specified)
Jan 26, 2021

Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4 mg QD
  • Tamsulosin 0.4 mg QD
  • Birmingham, Alabama
  • +94 more
Jan 26, 2021

Overactive Bladder Trial in Irwon-dong, Gyeonggi-do, Seoul (Tolterodine, Tolterodine 6)

Completed
  • Overactive Bladder
  • Tolterodine
  • Tolterodine 6
  • Irwon-dong, Seoul, Korea, Republic of
  • +3 more
Nov 28, 2019

Urinary Incontinence Trial in United States (Tolterodine ER 4 mg QD, OAB Patient Behavioral Training Material)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4 mg QD
  • OAB Patient Behavioral Training Material
  • Phoenix, Arizona
  • +50 more
Jan 26, 2021

Urinary Incontinence Trial in United States (Tolterodine ER 4mg QD)

Completed
  • Urinary Incontinence
  • Tolterodine ER 4mg QD
  • Chandler, Arizona
  • +57 more
Jan 26, 2021

Urinary Bladder, Overactive Trial in United States (tolterodine extended release)

Completed
  • Urinary Bladder, Overactive
  • tolterodine extended release
  • Birmingham, Alabama
  • +95 more
Jan 26, 2021

Spinal Vascular Disorder Nos, Overactive Bladder Trial (surgery, sacral neuromodulation, botulinum toxin A injection)

Not yet recruiting
  • Spinal Vascular Disorder Nos
  • Overactive Bladder
  • surgery
  • +3 more
  • (no location specified)
Apr 28, 2020

Overactive Bladder, Benign Prostatic Hyperplasia Trial in Seoul (doxazosin plus tolterodine SR)

Completed
  • Overactive Bladder
  • Benign Prostatic Hyperplasia
  • doxazosin plus tolterodine SR
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 28, 2019

Ureteral Obstruction Trial in Madison (Tamsulosin, Tolterodine ER)

Completed
  • Ureteral Obstruction
  • Madison, Wisconsin
    University of Wisconsin
Jun 20, 2019

Overactive Bladder in Taiwan, Korea and China

Completed
  • Overactive Bladder (OAB)
  • Daejeon, Korea, Republic of
  • +14 more
Apr 21, 2020

Overactive Bladder (OAB) Trial in Canada, United States (Mirabegron, Tolterodine ER)

Completed
  • Overactive Bladder (OAB)
  • Homewood, Alabama
  • +29 more
Feb 17, 2020

Among Overactive Bladder: A Retrospective Secondary Data

Completed
  • Overactive Bladder (OAB)
  • Sydney, Australia
  • +1 more
Oct 1, 2019